Logo
44th ANNUAL SCIENTIFIC MEETING OF INDONESIAN UROLOGICAL ASSOCIATION

44th ASMIUA

"Urological Science and Services in the Era of Artificial Intelligence"

1st - 5th September 2021

Download Announcement

VirConEx - ( )

Register to join the 44th ASMIUA
Register Now!

Faculties

International Faculties

  • Prof. Axel Merseburger (Germany)
  • Prof. Bhaskar Somani, MD (UK)
  • Prof. Enrique Lledó García, MD, PhD (Spain)*
  • Prof. Guido Giusti, MD, PhD (Italy)*
  • Prof. Igor Vaz (Mozambique)
  • Prof. Jeremy Teoh, MD, PhD (Hong Kong)
  • Prof. Jun Miki, MD (Japan)
  • Prof. Markus A. Kuczyk, MD (Germany)*
  • Prof. Olivier Traxer, MD (France)*
  • Anna Lawrence, MD (New Zealand)
  • Asif Muneer, MD (UK)
  • Bassem S Wadie, MD (Egypt)*
  • Hussain Alnajjar, MD (UK)*
  • Janak Desai, MD (India)
  • James A. Simon, MD (USA)
  • Juan Gómez Rivas, MD, PhD (Spain)
  • John Wiener, MD (USA)*
  • Neil Sheerin, MD, PhD (UK)*
  • Peter Black, MD (Canada)
  • Reynaldo Gómez, MD (Chile)*
  • Samuel Yrastorza, MD (Philippine)
  • Sanjay B. Kulkarni, MD (India)*
  • Siti Nur Masyithah binti Ma’arof (Malaysia)
  • Tran Toan, MD (Vietnam)
  • Warren Snodgrass, MD (USA)*

Indonesian Faculties

  • Prof. Akmal Taher, MD, PhD
  • Prof. Chaidir Arif Mochtar, MD, PhD
  • Prof. Doddy M. Soebadi, MD, PhD
  • Prof. Rainy Umbas, MD, PhD
  • Aaron Tigor Sihombing, MD, PhD
  • Achmad Rizky Herda Pratama, MD
  • Agus Rizal A.H. Hamid MD, PhD
  • Aga Parardya, MD
  • Ahmad Zulfan Hendri, MD
  • Andri Prawata
  • Andy Ardiansyah, MD
  • Anugrah Dianfitriani Santoso, MD, PhD
  • Ardy Santosa, MD
  • Arry Rodjani, MD
  • Badai Bhatara Tiksnadi, MD
  • Bambang S. Noegroho, MD, PhD
  • Besut Daryanto, MD, PhD
  • Boyke Soebhali, MD
  • Doddy W. Hami Seno, MD
  • Donny Eka Putra, MD
  • Dyandra Parikesit, MD
  • Etriyel Myh, MD, PhD
  • Ferry Safriadi, MD, PhD
  • Fikri Rizaldi, MD
  • Fina Widia, MD*
  • Gampo Alam Irdam, MD
  • Gede Wirya Duarsa, MD, PhD
  • Gerhard Reinaldi Situmorang, MD, PhD
  • Harrina Erlianti Rahardjo, MD, PhD
  • I Wayan Yudiana, MD
  • Indrawarman Soeroharjo, MD
  • Irfan Wahyudi, MD, PhD
  • Johan Renaldo, MD
  • Jufriady Ismy, MD
  • Jupiter Sibarani, MD, PhD
  • Kadek Budi Santosa, MD
  • Kuncoro Adi, MD
  • Kurnia Penta Seputra, MD
  • Lukman Hakim, MD, PhD
  • Moh. Ayodhia Soebadi MD, PhD
  • Muhammad Asykar Palinrungi, MD
  • Nanda Daniswara, MD
  • Ni Made Hustrini, MD, PhD
  • Nur Rasyid, MD, PhD
  • Octoveryal Aslim, MD
  • Paksi Satyagraha MD
  • Pande Made Wisnu Tirtayasa MD, PhD
  • Pandu Ishaq, MD
  • Ponco Birowo, MD, PhD
  • Poppy Desra S Nasution, MD
  • Pradana Nurhadi, MD
  • Prahara Yuri, MD
  • Putu Moda Arsana, MD*
  • Ricky Adriansjah, MD
  • Safendra Siregar, MD, PhD
  • Syah Mirsya Warli, MD
  • Sylvia Detri Elvira, MD
  • Tanaya Ghinorawa, MD
  • Tarmono, MD, PhD
  • Taufiq Nur Budaya, MD
  • Tjahjodjati, MD, PhD
  • Widi Atmoko, MD
  • Yacobda Hamonangan Sigumonrong, MD
  • Yevri Zulfiqar, MD, PhD

*within confirmation

Registration Information

Registered participants are entitled to admission to all scientific sessions. Each participant will receive user id and password for access the virtual exhibition in this website and zoom webinar link with unique code.

All scientific registrants must register as full participant and pay the relevant registration fees via credit card or bank transfer to :

Bank Name : Mandiri KCP Jakarta RSCM
Account Number : 122-00-1110883-7
Account Name : Perkumpulan Dokter Spesialis Urologi

Registration will not be confirmed until the committee has received the respective registration fee.

To register, please following link Register now and complete the registration together with your payment to the congress secretariat. Payment method can be through bank transfer or credit card.
Submission

Submission for Abstract

Abstract Guidelines

Please kindly pay attention to following guidelines:

Applied for Oral Free Paper, Poster Free Paper and Video Session. Special attention to Video Session presenter: you only require to submit the abstract (not the video).

Before submitting the abstract, you are requested to carefully read the rules regarding abstract submission.

  • Abstract(s) may not have been published previously at the time of presentation of the ASMIUA congress.
  • Any human experimentation that has been conducted with respect to the submitted abstract(s), should have been conducted according to the protocol approved by the institutional or local committee on ethics in human investigation; or, if no such committee exists, the works should have been conducted in accordance with the principles of the Declaration of Helsinki of World Medical Association. Council may enquire further into ethical aspects when evaluating the abstract(s). All research involving human and animal subjects require ethical clearance. The IRB number should be declared
  • In clinical studies, the authors must state that an Ethical Committee approval has been obtained
  • Copyright of the abstract(s) is assigned to the Indonesian Urological Association any conflicts with any other scientific association will be the sole responsibility of the author(s)
  • All abstracts that are published, including figures and tables, are the property of Indonesian Urological Association and are protected by copyright. Requests for reuse of material can be done through
  • The 44th ASMIUA Scientific Committee office reserves the right to obtain your raw data for statistical evaluation

  • All abstract(s) must be submitted in English. Applies also for the title, text body and author affiliations
  • Only abstract submitted through the website congress or congress email will be considered
  • Cancellation or name changes should be notified 1 month prior to the congress by online submission or email to asmiua2021@pharma-pro.com
  • Systematic reviews (with or without meta-analysis) can be submitted only when they meet the following standards :
    • The clinical question was clearly defined using a standard PICO (Population, Intervention, Comparison and Outcome) format
    • A comprehensive systematic literature search was carried out
    • An assessment of the risk of bias was made
    • Key findings are clearly described including clinical practice relevance

Authorship
Each quoted author should have contributed substantially to the represented work in terms of conceptual design or analysis writing of article and final approval of the article in order to take public responsibility for the content.

Size
The size of abstracts not more than 300 words and limited to 3,000 characters (including title, body of abstract, spaces tables and graphics). Every picture / graphic count for 500 characters..

Title
The title should clearly define the topic. Do not identify your institution in the title. There is no maximum length for the title. However, the characters in the title are included in your total character count. The first letter of the title will automatically begin with a capital letter. Do type the abstract and title in small letters, except for abbreviations. Do not type the abstract title in capital letters.

Authors
Type full family name and first name of all authors, only omitting any titles, degrees and institutional affiliations. It is advisable to check the correct spelling of the family name and initials with each author. Please check that for authors from the same institution, the name of institution is written in the exact same way to avoid the creation of extra affiliations, which are in fact identical.

Affiliation
Type the name of the institution, department, city and country in English.

Body of the abstract
The following headings have already been formatted for you and should not be entered in the text fields again:

  • Introduction & objectives
  • Materials & methods
  • Results
  • Conclusion

State the objective of the study, describe the material and methods, summarize the results presenting sufficient details to support of the conclusions reached (not acceptable to state: “The results will be discussed”). Use number for numbers and only very well-known abbreviations e.g. kg, MRI etc. If you must use other abbreviations, you must explain it the first time it appears. You can use the special keys to insert tables, pictures or specific characters

Proof reading
Verify that your abstract is correct and read the proof carefully that will be automatically shown after you have inserted all data. Keep a printout for your own records.

Editing
Abstract bodies will be published as submitted, except for a simple English spelling check. After submission deadline there is no possibility to edit the abstract anymore.

Submission deadline
Deadline for abstract submission is July 15th, 2021 at 2PM local time. In case you want to withdraw your abstract after submission, please send an email before August 1st, 2021 to asmiua2021@pharma-pro.com

Submission
Submit your abstract through congress website www.asmiu2021.org or via congress email asmiua2021@pharma-pro.com before the deadline.

Presentation
The scientific committee will give the final decision on the presentation format for each accepted abstract. However, presenters are welcome to inform the committee the preference of the presentation format. Please note down at the top of your abstract ONE of the following preferences: ORAL PRESENTATION / POSTER PRESENTATION / VIDEO SESSION.
The final presentation format and schedule be informed by email to each author at the latest by August 1st, 2021. The presentation schedule will be only provided for those presenters that have paid the registration fee.

Online Submission

Abstract Submission has been close

*make sure the file is in accordance with the guideline.

Video Competition

Video Competition

Syarat dan Ketentuan Lomba Kategori "Video Competition”

See More
Educative Video Competition

Syarat dan Ketentuan Lomba Kategori “Educative Video Competition”:

See More

List of Sponsors

Diamond

Platinum

Gold

Silver

Other